SIMPLIFYING CLONING.
Published In: TIME Magazine, 2025, v. 206, n. 13/14. P. 61 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Kluger, Jeffrey 3 of 3
Abstract
The article focuses on Colossal Biosciences' innovative approach to cloning as a means to combat biodiversity loss. The company has developed a method to clone animals using endothelial progenitor cells (EPCs), which can be obtained through a simple blood draw, rather than the more invasive techniques previously used. This advancement is seen as a more humane and efficient way to preserve the genetic heritage of endangered species, as highlighted by CEO Ben Lamm. The technique aims to aid in the conservation of the approximately 47,000 species currently threatened with extinction. [Extracted from the article]
Additional Information
- Source:TIME Magazine. 2025/10, Vol. 206, Issue 13/14, p61
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2025
- ISSN:0040-781X
- Accession Number:188770679
- Copyright Statement:Copyright of TIME Magazine is the property of TIME USA, LLC and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.